| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,266 |
9,174 |
$1.74M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,724 |
5,627 |
$1.39M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,585 |
1,494 |
$498K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,967 |
3,877 |
$475K |
| 80053 |
Comprehensive metabolic panel |
14,598 |
11,959 |
$468K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,828 |
5,987 |
$405K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,610 |
12,636 |
$290K |
| 36415 |
Collection of venous blood by venipuncture |
21,223 |
16,506 |
$180K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,811 |
3,461 |
$149K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,308 |
3,783 |
$132K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
865 |
747 |
$121K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
954 |
783 |
$120K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,179 |
934 |
$105K |
| 80061 |
Lipid panel |
3,476 |
3,097 |
$100K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,813 |
3,315 |
$93K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,072 |
804 |
$66K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
217 |
64 |
$65K |
| 81001 |
|
5,595 |
4,624 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
599 |
471 |
$55K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
798 |
669 |
$55K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,187 |
1,045 |
$49K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
598 |
377 |
$49K |
| 84484 |
|
1,237 |
925 |
$47K |
| 84439 |
|
1,922 |
1,672 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
1,704 |
985 |
$42K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
294 |
225 |
$41K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
818 |
225 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
391 |
350 |
$27K |
| 90837 |
Psychotherapy, 53 minutes with patient |
206 |
61 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
359 |
222 |
$22K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,091 |
809 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
51 |
24 |
$19K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
335 |
283 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
21 |
12 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
258 |
206 |
$14K |
| 83690 |
|
308 |
261 |
$13K |
| 72100 |
|
131 |
91 |
$12K |
| 86769 |
|
268 |
240 |
$11K |
| 83735 |
|
567 |
446 |
$11K |
| 87088 |
|
483 |
403 |
$11K |
| 85610 |
|
1,755 |
878 |
$10K |
| 0012A |
|
489 |
425 |
$10K |
| 86140 |
|
494 |
418 |
$10K |
| 82607 |
|
226 |
214 |
$10K |
| 0011A |
|
471 |
412 |
$9K |
| A9270 |
Non-covered item or service |
5,539 |
3,707 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
346 |
296 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
66 |
55 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
236 |
209 |
$8K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
228 |
130 |
$8K |
| 82728 |
|
164 |
141 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
59 |
55 |
$7K |
| 83605 |
|
205 |
160 |
$7K |
| 99215 |
Prolong outpt/office vis |
132 |
78 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
561 |
339 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
38 |
24 |
$6K |
| 83874 |
|
199 |
155 |
$6K |
| 90834 |
Psychotherapy, 45 minutes with patient |
67 |
25 |
$6K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
660 |
475 |
$5K |
| 85652 |
|
334 |
295 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
377 |
322 |
$5K |
| 87186 |
|
149 |
126 |
$4K |
| 83880 |
|
91 |
71 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
25 |
13 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
52 |
40 |
$4K |
| 0064A |
|
205 |
171 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
219 |
149 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
36 |
28 |
$3K |
| 73030 |
|
37 |
25 |
$3K |
| 83550 |
|
138 |
126 |
$3K |
| 82553 |
|
92 |
66 |
$3K |
| 83540 |
|
127 |
117 |
$2K |
| 94762 |
|
30 |
24 |
$2K |
| 93793 |
|
352 |
124 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
64 |
60 |
$2K |
| 82550 |
|
94 |
66 |
$2K |
| 73562 |
|
26 |
12 |
$1K |
| 90686 |
|
86 |
76 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
148 |
127 |
$1K |
| 82150 |
|
56 |
40 |
$998.69 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
23 |
13 |
$993.57 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
24 |
$957.71 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
31 |
26 |
$940.11 |
| 82570 |
|
57 |
50 |
$914.64 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
49 |
48 |
$866.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
72 |
45 |
$773.53 |
| 96127 |
|
191 |
126 |
$741.46 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32 |
30 |
$729.49 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
143 |
125 |
$674.35 |
| 82746 |
|
13 |
13 |
$654.78 |
| 86038 |
|
12 |
12 |
$640.50 |
| 36416 |
|
958 |
339 |
$568.55 |
| 86703 |
|
15 |
14 |
$524.70 |
| 87400 |
|
27 |
15 |
$495.00 |
| 86803 |
|
15 |
14 |
$472.71 |
| 80069 |
|
19 |
13 |
$314.82 |
| 86780 |
|
13 |
12 |
$294.32 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
24 |
14 |
$291.02 |
| 82043 |
|
14 |
12 |
$152.15 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16 |
16 |
$136.70 |
| 99406 |
|
16 |
13 |
$110.30 |